- Home
- PED vs MRSN Comparison
PED vs MRSN Comparison
Compare PED & MRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PED
- MRSN
- Stock Information
- Founded
- PED N/A
- MRSN 2001
- Country
- PED United States
- MRSN United States
- Employees
- PED N/A
- MRSN N/A
- Industry
- PED Oil & Gas Production
- MRSN Biotechnology: Pharmaceutical Preparations
- Sector
- PED Energy
- MRSN Health Care
- Exchange
- PED Nasdaq
- MRSN Nasdaq
- Market Cap
- PED 55.4M
- MRSN 47.1M
- IPO Year
- PED N/A
- MRSN 2017
- Fundamental
- Price
- PED $0.59
- MRSN $8.35
- Analyst Decision
- PED Strong Buy
- MRSN Strong Buy
- Analyst Count
- PED 1
- MRSN 3
- Target Price
- PED $1.50
- MRSN $33.00
- AVG Volume (30 Days)
- PED 210.8K
- MRSN 67.0K
- Earning Date
- PED 11-12-2025
- MRSN 11-13-2025
- Dividend Yield
- PED N/A
- MRSN N/A
- EPS Growth
- PED 569.41
- MRSN N/A
- EPS
- PED 0.14
- MRSN N/A
- Revenue
- PED $35,334,000.00
- MRSN $34,769,000.00
- Revenue This Year
- PED N/A
- MRSN N/A
- Revenue Next Year
- PED $17.41
- MRSN N/A
- P/E Ratio
- PED $4.52
- MRSN N/A
- Revenue Growth
- PED 3.93
- MRSN 16.14
- 52 Week Low
- PED $0.47
- MRSN $5.21
- 52 Week High
- PED $1.00
- MRSN $70.75
- Technical
- Relative Strength Index (RSI)
- PED 47.28
- MRSN 42.08
- Support Level
- PED $0.56
- MRSN $8.00
- Resistance Level
- PED $0.65
- MRSN $9.87
- Average True Range (ATR)
- PED 0.04
- MRSN 0.65
- MACD
- PED -0.00
- MRSN -0.29
- Stochastic Oscillator
- PED 22.84
- MRSN 11.21
About PED Pedevco Corp.
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.